These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6234253)
1. Molecular mechanism of fibrinolysis--a system involved with malignant cells. Cederholm-Williams SA Invasion Metastasis; 1981; 1(2):85-98. PubMed ID: 6234253 [No Abstract] [Full Text] [Related]
2. [The regulation of fibrinolysis]. Matsuo O Nihon Rinsho; 1989 Apr; 47(4):739-45. PubMed ID: 2526261 [No Abstract] [Full Text] [Related]
3. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent]. Collen D Verh K Acad Geneeskd Belg; 1982; 44(5-6):295-305. PubMed ID: 6223460 [No Abstract] [Full Text] [Related]
8. Biological role of fibrinolysis. Davidson JF; Walker ID J Clin Pathol Suppl (R Coll Pathol); 1980; 14():1-4. PubMed ID: 6448868 [No Abstract] [Full Text] [Related]
9. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. Sakata Y; Aoki N J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538 [TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis--a review. Kane KK Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [TBL] [Abstract][Full Text] [Related]
12. [Development of research into the physiology and pathophysiology of the fibrinolysis system]. Andreenko GV Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082 [TBL] [Abstract][Full Text] [Related]
13. [Tissue plasminogen activator: mechanism of action and thrombolytic properties]. Páramo JA; Collen D Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389 [No Abstract] [Full Text] [Related]
14. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin. Lijnen HR; Collen D Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318 [No Abstract] [Full Text] [Related]
15. [Blood coagulation mechanism from the viewpoint of molecular biochemistry]. Hashimoto S; Asai K Rinsho Byori; 1985 Sep; 33(9):957-9. PubMed ID: 2934563 [No Abstract] [Full Text] [Related]
16. [Therapeutic advances against thromboembolic disease: II. The use of tissue fibrinolysis activator as a thrombolytic agent]. Rueda F; Félez J Sangre (Barc); 1984; 29(4-A):429-48. PubMed ID: 6390755 [No Abstract] [Full Text] [Related]
17. The biological role of fibrinolysis. Davidson JF; Walker ID Adv Exp Med Biol; 1984; 164():229-34. PubMed ID: 6538057 [No Abstract] [Full Text] [Related]
19. [Role of plasminogen binding site of alpha 2-plasmin inhibitor on the initiation and regulation of fibrinolysis]. Iwamoto M; Sugiyama N Rinsho Byori; 1989 Apr; Spec No 81():118-25. PubMed ID: 2526883 [No Abstract] [Full Text] [Related]
20. [Modern concepts of the hemostatic and fibrinolytic systems]. Andreenko GV Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102 [No Abstract] [Full Text] [Related] [Next] [New Search]